We provide you with 20 years of free, institutional-grade data for MDXH stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MDXH. Explore the full financial landscape of MDXH stock.
Reported Date | CIK | Ticker | Type |
---|
MDxHealth SA(NASDAQ:MDXH)


MDxHealth SA operates as a molecular diagnostics company in Belgium, the Netherlands, Spain, Poland, Italy, the United States, rest of European Union, and internationally. The company develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatmen...
The information provided in this report about MDXH stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.